Back to results
US 10,457,711 B2Granted
Dermatophagoides farinae protein
AssigneeTaiho Pharmaceutical Co., Ltd.
InventorsNaomasa Asaka, Yuki Tanaka, Naoki Inagaki
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeTaiho Pharmaceutical Co., Ltd.
InventorsNaomasa Asaka, Yuki Tanaka, Naoki Inagaki
Estimating the term…
Provided are a novel Dermatophagoides farinae protein, and a diagnostic drug, a prophylactic drug and a therapeutic drug for an allergic disease caused by Dermatophagoides farinae. A Dermatophagoides farinae protein selected from the group consisting of the following (a) to (c), or a fragment peptide thereof: (a) a protein including an amino acid sequence set forth in SEQ ID NO:2; (b) a protein including an amino acid sequence in which one or several amino acids have been substituted, deleted, or added relative to the amino acid sequence set forth in SEQ ID NO:2, and having allergenicity of Dermatophagoides farinae; and (c) a protein including an amino acid sequence having 90% or higher identity with the amino acid sequence set forth in SEQ ID NO:2, and having allergenicity of Dermatophagoides farinae.
A method for preventing or treating an allergic disease caused by Dermatophagoides farinae, the method comprising administering a Dermatophagoides farinae protein selected from the group consisting of (a), (b) and (c) below, or a fragment peptide comprising 10 to 34 amino acid residues of (a), (b) or (c) below, to a patient in need thereof:
A method for detecting an allergic disease caused by Dermatophagoides farinae, the method comprising administering a Dermatophagoides farinae protein selected from the group consisting of (a), (b) and (c) below, or a fragment peptide comprising 10 to 34 amino acid residues of (a), (b) or (c) below, to a test subject in need thereof, and measuring an allergic state of the test subject:
Dependencies are inferred from the claim text.